ClinicalTrialsFinder
RecruitingNCT06830590

Study of Molecular Characterisation of Early Operable Primary Breast Cancer in Pakistani Population

Sponsor

Liaquat University of Medical & Health Sciences

Enrollment

300 participants

Start Date

Feb 1, 2016

Study Type

OBSERVATIONAL

Conditions

Breast CancerTreatmentMolecular Pathway Deregulation

Summary

This study is looking at the biological characteristics of early operable primary breast cancer in Pakistani Population by using IHC

Eligibility

Sex: FEMALE

Inclusion Criteria1

  • Women with confirmed diagnosis of breast cancer without history of taking neoadjuvant therapy Good quality tumour samples available for IHC

Exclusion Criteria1

  • patients received pre-operative chemotherapy or radiotherapy

Interventions

PROCEDUREMolecular characterisation

All patients treated by surgery were included without any neoadjuvant therapy

Locations(1)

Binafsha M Syed

Jamshoro, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06830590

Related Trials

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT0661828763 locations

Early Phase Study of KESONOTIDE™in Participants With Solid Tumours

NCT069260753 locations

Cardiac Outcomes With Near-Complete Estrogen Deprivation

NCT053096553 locations

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

NCT041190243 locations

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

NCT074780161 location